A detailed history of Whalerock Point Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Whalerock Point Partners, LLC holds 41,715 shares of PFE stock, worth $1.16 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
41,715
Previous 41,676 0.09%
Holding current value
$1.16 Million
Previous $1.16 Million 0.95%
% of portfolio
0.31%
Previous 0.33%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $985 - $1,154
39 Added 0.09%
41,715 $1.17 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $144,336 - $165,744
-5,575 Reduced 11.8%
41,676 $1.16 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $23,726 - $30,817
-908 Reduced 1.89%
47,251 $1.36 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $83,434 - $97,526
-2,600 Reduced 5.12%
48,159 $1.6 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $9,969 - $11,534
276 Added 0.55%
50,759 $1.86 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $105,959 - $137,943
2,690 Added 5.63%
50,483 $2.06 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $20,165 - $26,323
483 Added 1.02%
47,793 $2.45 Million
Q3 2022

Nov 16, 2022

BUY
$43.76 - $53.42 $1.98 Million - $2.42 Million
45,240 Added 2185.51%
47,310 $2.07 Million
Q3 2022

Nov 15, 2022

SELL
$43.76 - $53.42 $1.91 Million - $2.33 Million
-43,595 Reduced 95.47%
2,070 $2.07 Billion
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $2,326 - $2,758
50 Added 0.11%
45,665 $2.39 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $13,725 - $17,007
300 Added 0.66%
45,615 $2.36 Billion
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $34,089 - $50,531
825 Added 1.85%
45,315 $2.68 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $51,025 - $65,546
1,300 Added 3.01%
44,490 $1.91 Million
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $3,590 - $4,068
-100 Reduced 0.23%
43,190 $1.69 Billion
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $306,433 - $345,595
-9,150 Reduced 17.45%
43,290 $1.57 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $1.7 Million - $2.16 Million
50,660 Added 2846.07%
52,440 $1.93 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $1.44 Million - $1.69 Million
-45,310 Reduced 96.22%
1,780 $61,000
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $952,635 - $1.16 Million
-31,628 Reduced 40.18%
47,090 $1.54 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $5,324 - $7,608
-197 Reduced 0.25%
78,718 $2.57 Million
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $688,324 - $781,160
-20,909 Reduced 20.95%
78,915 $3.09 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $6,920 - $8,973
-213 Reduced 0.21%
99,824 $3.59 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $285,000 - $313,120
7,600 Added 8.22%
100,037 $4.25 Million
Q2 2018

Mar 04, 2019

SELL
$32.98 - $35.16 $305,065 - $325,229
-9,250 Reduced 9.1%
92,437 $3.35 Million
Q1 2018

Apr 05, 2018

SELL
$31.91 - $37.02 $3,191 - $3,702
-100 Reduced 0.1%
101,687 $3.61 Million
Q4 2017

Jan 16, 2018

SELL
$33.26 - $35.29 $24,945 - $26,467
-750 Reduced 0.73%
101,787 $3.69 Million
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $3.18 Million - $3.5 Million
102,537
102,537 $3.66 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Whalerock Point Partners, LLC Portfolio

Follow Whalerock Point Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalerock Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whalerock Point Partners, LLC with notifications on news.